BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32523045)

  • 1. A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities.
    Narayan RS; Molenaar P; Teng J; Cornelissen FMG; Roelofs I; Menezes R; Dik R; Lagerweij T; Broersma Y; Petersen N; Marin Soto JA; Brands E; van Kuiken P; Lecca MC; Lenos KJ; In 't Veld SGJG; van Wieringen W; Lang FF; Sulman E; Verhaak R; Baumert BG; Stalpers LJA; Vermeulen L; Watts C; Bailey D; Slotman BJ; Versteeg R; Noske D; Sminia P; Tannous BA; Wurdinger T; Koster J; Westerman BA
    Nat Commun; 2020 Jun; 11(1):2935. PubMed ID: 32523045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms.
    Ariey-Bonnet J; Berges R; Montero MP; Mouysset B; Piris P; Muller K; Pinna G; Failes TW; Arndt GM; Morando P; Baeza-Kallee N; Colin C; Chinot O; Braguer D; Morelli X; André N; Carré M; Tabouret E; Figarella-Branger D; Le Grand M; Pasquier E
    EBioMedicine; 2023 Sep; 95():104752. PubMed ID: 37572644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated framework for identification of effective and synergistic anti-cancer drug combinations.
    Sharma A; Rani R
    J Bioinform Comput Biol; 2018 Oct; 16(5):1850017. PubMed ID: 30304987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients.
    He L; Tang J; Andersson EI; Timonen S; Koschmieder S; Wennerberg K; Mustjoki S; Aittokallio T
    Cancer Res; 2018 May; 78(9):2407-2418. PubMed ID: 29483097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratification and prediction of drug synergy based on target functional similarity.
    Yang M; Jaaks P; Dry J; Garnett M; Menden MP; Saez-Rodriguez J
    NPJ Syst Biol Appl; 2020 Jun; 6(1):16. PubMed ID: 32487991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico drug combination discovery for personalized cancer therapy.
    Jeon M; Kim S; Park S; Lee H; Kang J
    BMC Syst Biol; 2018 Mar; 12(Suppl 2):16. PubMed ID: 29560824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Computational Approach for Identifying Synergistic Drug Combinations.
    Gayvert KM; Aly O; Platt J; Bosenberg MW; Stern DF; Elemento O
    PLoS Comput Biol; 2017 Jan; 13(1):e1005308. PubMed ID: 28085880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes.
    Regan-Fendt KE; Xu J; DiVincenzo M; Duggan MC; Shakya R; Na R; Carson WE; Payne PRO; Li F
    NPJ Syst Biol Appl; 2019; 5():6. PubMed ID: 30820351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer.
    Jaeger S; Igea A; Arroyo R; Alcalde V; Canovas B; Orozco M; Nebreda AR; Aloy P
    Cancer Res; 2017 Jan; 77(2):459-469. PubMed ID: 27879272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems modelling of the EGFR-PYK2-c-Met interaction network predicts and prioritizes synergistic drug combinations for triple-negative breast cancer.
    Shin SY; Müller AK; Verma N; Lev S; Nguyen LK
    PLoS Comput Biol; 2018 Jun; 14(6):e1006192. PubMed ID: 29920512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer network activity associated with therapeutic response and synergism.
    Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
    Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boolean modeling of breast cancer signaling pathways uncovers mechanisms of drug synergy.
    Taoma K; Ruengjitchatchawalya M; Liangruksa M; Laomettachit T
    PLoS One; 2024; 19(2):e0298788. PubMed ID: 38394152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network Propagation Predicts Drug Synergy in Cancers.
    Li H; Li T; Quang D; Guan Y
    Cancer Res; 2018 Sep; 78(18):5446-5457. PubMed ID: 30054332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple gene set-based method accurately predicts the synergy of drug pairs.
    Hsu YC; Chiu YC; Chen Y; Hsiao TH; Chuang EY
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):66. PubMed ID: 27585722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks.
    Pivetta T; Isaia F; Trudu F; Pani A; Manca M; Perra D; Amato F; Havel J
    Talanta; 2013 Oct; 115():84-93. PubMed ID: 24054565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning.
    Chen X; Ren B; Chen M; Wang Q; Zhang L; Yan G
    PLoS Comput Biol; 2016 Jul; 12(7):e1004975. PubMed ID: 27415801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Drug Combination Prediction by Integrating Multiomics Data in Deep Learning Models.
    Zhang T; Zhang L; Payne PRO; Li F
    Methods Mol Biol; 2021; 2194():223-238. PubMed ID: 32926369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
    BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.